Boditech Med Inc. (KOSDAQ: 206640)

Market Cap	358.22B
Revenue (ttm)	141.86B
Net Income (ttm)	27.30B
Shares Out	21.98M
EPS (ttm)	1,242.03
PE Ratio	13.12
Forward PE	10.14
Dividend	200.00 (1.23%)
Ex-Dividend Date	n/a

Volume	155,877
Open	16,670
Previous Close	16,570
Day's Range	15,650 - 16,670
52-Week Range	13,350 - 22,150
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 19, 2025

About Boditech Med

Boditech Med Inc. offers instruments and diagnostic reagents in South Korea and internationally. The company offers instruments, including ichroma II, diagnostic immuno-analyzer to measure the presence of various biomarkers for cardiac, cancer, hormones, infectious diseases, autoimmune diseases, and metabolic diseases; ichroma III, a high-throughput immuno-analyzer that enables simultaneous testing for various parameters; ExAmplar, a compact real time PCR that detects virus/bacteria quantitatively or qualitatively using ready-to-use cartridges;...

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 1998
• Employees: 491
• Stock Exchange: KOSDAQ
• Ticker Symbol: 206640

Financial Performance

In 2023, Boditech Med's revenue was 134.22 billion, an increase of 13.67% compared to the previous year's 118.08 billion. Earnings were 25.95 billion, an increase of 7.43%.